Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;25(8):2413-2418.
doi: 10.1111/dom.15109. Epub 2023 May 11.

Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

Taha Sen  1 , Viktor Rotbain Curovic  2 , Niels Jongs  1 , Gozewijn D Laverman  3 , Adriaan Kooy  4 , Frederik Persson  2 , Peter Rossing  2 , Hiddo J L Heerspink  1   5
Affiliations

Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

Taha Sen et al. Diabetes Obes Metab. 2023 Aug.
No abstract available

Keywords: ARB; DPP-4 inhibitor; JAK-STAT inhibitor; SGLT2 inhibitor; baricitinib; empagliflozin; inflammation; inflammatory markers; linagliptin; telmisartan.

PubMed Disclaimer

References

REFERENCES

    1. Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5(3):393-398.
    1. Hayashi M, Takeshita K, Uchida Y, et al. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance. PLoS One. 2014;9(12):e116163.
    1. Mizuno M, Sada T, Kato M, Fukushima Y, Terashima H, Koike H. The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes. J Cardiovasc Pharmacol. 2006;48(4):135-142.
    1. Pavlatou MG, Mastorakos G, Margeli A, et al. Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation. Eur J Clin Invest. 2011;41(6):652-658.
    1. Sen T, Li J, Neuen BL, et al. Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial. Diabetologia. 2021;64(10):2147-2158.

Publication types

MeSH terms

LinkOut - more resources